Glycobiology Advance Access published online on January 20, 2006
Glycobiology, doi:10.1093/glycob/cwj079
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Biochemistry, Osaka University Medical School, Osaka, 565-0871, Japan
* To whom correspondence should be addressed. Malignant transformation is often accompanied by an aberrant glycosylation profile of the cell surface, in particular, the production of GlcNAc
Received December 1, 2005
Revised January 12, 2006
Accepted January 15, 2006
Article
A specific detection of GlcNAc
Tae Watanabe 1,
Hideyuki Ihara 1,
Eiji Miyoshi 1,
Koichi Honke 2,
Naoyuki Taniguchi 1,
and
Tomohiko Taguchi 1 *
1-6Man
1- branches in N-linked glycoproteins based on the specificity of N-acetylglucosaminyltransferase VI
2 Department of Molecular Genetics, Kochi University Medical School, Kochi, 783-8505, Japan
Tomohiko Taguchi, E-mail: tom_taguchi{at}biochem.med.osaka-u.ac.jp
![]()
Abstract
1-6Man
1- branches in N-linked glycoproteins. In order to identify the target glycoproteins, here we show a method using recombinant chicken N-acetylglucosaminyltransferase VI (GnT VI) and radiolabeled UDP-GlcNAc. The assay exploits the fact that GnT VI has a strict requirement for the GlcNAc
1-6Man
1- structure for activity, when a pyridylaminated free N-glycan is used as the acceptor substrate. Human asialo-agalacto
1-acid glycoprotein (AGP), which is known to contain GlcNAc
1-6Man
1- branches in its N-linked glycan chains was radiolabeled when reacted with GnT VI, whereas human asialo-agalacto trasnferrin and bovine fetuin, neither of which contains a GlcNAc
1-6Man
1- structure were not, thus corroborating the specificity of the assay. Several proteins from human serum after pretreatment with sialidase and
-galactosidase could be detected using the assay. One was identified as AGP, from its mobility on SDS-PAGE, demonstrating the potential of this assay even with crude materials. Furthermore, this method could detect a protein which was also positively stained with leukoagglutinating phytohemagglutinin (L4-PHA), using glycoproteins prepared from WiDr human colon cancer cells. This method should provide a useful complement to the current method, which relies on the specificity of L4-PHA.
1-acid glycoprotein/GlcNAc
1-6Man
1- branch/GnT V/GnT VI/cancer cells.
![]()
CiteULike
Connotea
Del.icio.us What's this?